Abstract:Background/Aims: Hepatic ischemia-reperfusion (I/R) injury, which is mainly induced by inflammation and unstable intracellular ions, is a major negative consequence of surgery that compromises hepatic function. However, the exact mechanisms of liver I/R injury have not been determined. Positive crosstalk with the Ca2+/CaMKII pathway is required for complete activation of the TLR4 pathway and inflammation. We previously found that miR-148a, which decreased in abundance with increasing reperfusion time, targeted and repressed the expression of CaMKIIα. In the present study, we examined the role of the miR-148a machinery in I/R-induced Ca2+/CaMKII and TLR4 signaling changes, inflammation, and liver dysfunction in vivo and in vitro. Methods: Liver function was evaluated by serum aminotransferase levels and hematoxylin-eosin (HE) staining. Inflammatory factors were detected by enzyme-linked immunosorbent assay. Gene and protein expression were assessed by RT-PCR and western blot. Small interfering RNA was used to silence target gene expression. HE staining and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling were used to measure hepatic tissue apoptosis. These assays were performed to identify factors upregulated in hepatic I/R injury and downregulated by miR-148a. Results: We manifested that expression of CaMKIIα and phosphorylation of TAK1 and IRF3 were elevated in hypoxia/reoxygenation (H/R)-treated primary Kupffer cells (KCs) and liver tissue of I/R-treated mice, but these effects were attenuated by treatment with miR-148a mimic and were accompanied by the alleviation of liver dysfunction and hepatocellular apoptosis. Luciferase reporter experiments showed that miR148a suppressed luciferase activity by almost 60%. Moreover, knockdown of CaMKIIα in H/R KCs led to significant deficiencies in p-TAK1, P-IRF3, IL-6, and TNF-α, which was consistent with the effects of miR-148a overexpression. Otherwise, the same trend of activation of TAK1 and IRF3 and inflammatory factors in vitro was observed in the siTAK1 + siIRF3 group compared with the siCaMKIIα group. Conclusion: Taken together, we conclude that miR-148a may mitigate hepatic I/R injury by ameliorating TLR4-mediated inflammation via targeting CaMKIIα in vitro and in vivo.

Mir-30B Inhibits Autophagy to Alleviate Hepatic Ischemia-Reperfusion Injury Via Decreasing the Atg12-Atg5 Conjugate.

Targeting the Mir-665-3p-atg4b-autophagy Axis Relieves Inflammation and Apoptosis in Intestinal Ischemia/reperfusion

Inhibition of Mir-450B-5p Ameliorates Hepatic Ischemia/reperfusion Injury Via Targeting CRYAB

Inhibition of Mir-34A-5p Alleviates Hypoxia-Reoxygenation Injury by Enhancing Autophagy in Steatotic Hepatocytes

MicroRNA-101 Inhibits Autophagy to Alleviate Liver Ischemia/reperfusion Injury Via Regulating the Mtor Signaling Pathway.

miR-451-3p alleviates myocardial ischemia/reperfusion injury by inhibiting MAP1LC3B-mediated autophagy

A Role of Microrna‐370 in Hepatic Ischaemia‐reperfusion Injury by Targeting Transforming Growth Factor‐β Receptor II

Interferon Regulatory Factor 1 Activates Autophagy to Aggravate Hepatic Ischemia-Reperfusion Injury by Increasing High Mobility Group Box 1 Release.

Mir-17-5p Attenuates Kidney Ischemia-Reperfusion Injury by Inhibiting the PTEN and BIM Pathways.

Downregulation of Mirna-30A Enhanced Autophagy in Osthole-Alleviated Myocardium Ischemia/reperfusion Injury.

MiR-139-5p Protect Against Myocardial Ischemia and Reperfusion (I/R) Injury by Targeting Autophagy-Related 4D and Inhibiting AMPK/mTOR/ULK1 Pathway.

MiR-302a-3p aggravates myocardial ischemia-reperfusion injury by suppressing mitophagy via targeting FOXO3

Microrna-449b-5p Targets Hmgb1 To Attenuate Hepatocyte Injury In Liver Ischemia And Reperfusion

Mir‑30c Reduces Myocardial Ischemia/reperfusion Injury by Targeting SOX9 and Suppressing Pyroptosis

Anti-Apoptotic Effect of Microrna-30b in Early Phase of Rat Myocardial Ischemia-Reperfusion Injury Model

MiR-1395 p protect against myocardial ischemia and reperfusion ( I / R ) injury by targeting autophagy-related 4 D and inhibiting AMPK / mTOR / ULK 1 pathway

Role of Mir-148A in Mitigating Hepatic Ischemia-Reperfusion Injury by Repressing the TLR4 Signaling Pathway Via Targeting CaMKIIα in Vivo and in Vitro

Interferon Regulatory Factor-1 Activates Autophagy to Aggravate Hepatic Ischemia-Reperfusion Injury Via the P38/P62 Pathway in Mice.

MiR-204 regulates cardiomyocyte autophagy induced by ischemia-reperfusion through LC3-II

Role of Autophagy and Its Signaling Pathways in Ischemia/reperfusion Injury

Downregulation Of Mir-34a Attenuates Myocardial Ischemia/Reperfusion Injury By Inhibiting Cardiomyocyte Apoptosis